# The Analgesic Effect of Scalp Nerve Block Using Bupivacaine Liposomes for Postoperative Pain Relief After Craniotomy

> **NCT07049094** · PHASE4 · RECRUITING · sponsor: **Zhejiang University** · enrollment: 218 (estimated)

## Conditions studied

- Brain Tumor Adult
- Cerebrovascular Disease

## Interventions

- **DRUG:** scalp nerve block with 0.25% hydrochloride bupivacaine and 0.67% bupivacaine liposome solution
- **DRUG:** scalp nerve block with 0.50% hydrochloride bupivacaine

## Key facts

- **NCT ID:** NCT07049094
- **Lead sponsor:** Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-25
- **Primary completion:** 2027-06-25
- **Final completion:** 2027-12-31
- **Target enrollment:** 218 (ESTIMATED)
- **Last updated:** 2025-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07049094

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07049094, "The Analgesic Effect of Scalp Nerve Block Using Bupivacaine Liposomes for Postoperative Pain Relief After Craniotomy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07049094. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*